Teva Urges Federal Circuit to Reinstate Inhaler Patents in Government Database

Teva Pharmaceuticals USA Inc. has called on the Federal Circuit to reverse a lower court ruling that removed inhaler device patents from a critical government database. This delisting was secured by Amneal Pharmaceuticals Inc. following an infringement lawsuit. Teva contends that the decision disregards the broad protections intended under intellectual property law, potentially impacting the scope of patent protections. For further details, please refer to the original article on Law360.